Gene · 55
Papers3,704
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,704
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immunotherapy as a potential treatment approach for currently incurable bone metastasis. | J Bone Miner Metab | 2023 | 36752903 | PubTator, text mining | PubMed |
| Barriers to Treg therapy in Europe: From production to regulation. | Front Med (Lausanne) | 2023 | 36744143 | PubTator, text mining | PubMed |
| Therapeutic Vaccination for HPV-Mediated Cancers. | Curr Otorhinolaryngol Rep | 2023 | 36743978 | PubTator, text mining | PubMed |
| Cell-Based Drug Delivery Systems with Innate Homing Capability as a Novel Nanocarrier Platform. | Int J Nanomedicine | 2023 | 36742991 | PubTator, text mining | PubMed |
| Sebaceous Carcinoma of the Penis: A Rare, Dangerous Clinical Entity and the Importance of Immunohistochemistry in Diagnosis. | Case Rep Dermatol Med | 2023 | 36741940 | PubTator, text mining | PubMed |
| Defining T cell receptor repertoires using nanovial-based affinity and functional screening. | bioRxiv | 2023 | 36711524 | PubTator, text mining | PubMed |
| Prostate cancer extracellular vesicle digital scoring assay - a rapid noninvasive approach for quantification of disease-relevant mRNAs. | Nano Today | 2023 | 36711067 | PubTator, text mining | PubMed |
| Network pharmacology-based analysis of heat clearing and detoxifying drug JC724 on the treatment of colorectal cancer. | World J Gastrointest Oncol | 2023 | 36684054 | PubTator, text mining | PubMed |
| Targeted Radiation and Immune Therapies-Advances and Opportunities for the Treatment of Prostate Cancer. | Pharmaceutics | 2023 | 36678880 | PubTator, text mining | PubMed |
| Selected strategies to fight pathogenic bacteria. | J Enzyme Inhib Med Chem | 2023 | 36629427 | PubTator, text mining | PubMed |
| Peptide Drug Conjugates and Their Role in Cancer Therapy. | Int J Mol Sci | 2023 | 36614268 | PubTator, text mining | PubMed |
| Sorting Transcriptomics Immune Information from Tumor Molecular Features Allows Prediction of Response to Anti-PD1 Therapy in Patients with Advanced Melanoma. | Int J Mol Sci | 2023 | 36614248 | PubTator, text mining | PubMed |
| Developing quantitative assays for six urinary glycoproteins using parallel reaction monitoring, data-independent acquisition, and TMT-based data-dependent acquisition. | Proteomics | 2023 | 36592098 | PubTator, text mining | PubMed |
| Differentially expressed glycoproteins in pre- and post-digital rectal examination urine samples for detecting aggressive prostate cancer. | Proteomics | 2023 | 36479985 | PubTator, text mining | PubMed |
| Nanoformulations targeting immune cells for cancer therapy: mRNA therapeutics. | Bioact Mater | 2023 | 36471724 | PubTator, text mining | PubMed |
| Instigation of the epoch of nanovaccines in cancer immunotherapy. | Wiley Interdiscip Rev Nanomed Nanobiotechnol | 2023 | 36410742 | PubTator, text mining | PubMed |
| Cellular Cancer Immunotherapy Development and Manufacturing in the Clinic. | Clin Cancer Res | 2023 | 36383184 | PubTator, text mining | PubMed |
| The Cancer Epitope Database and Analysis Resource (CEDAR). | Nucleic Acids Res | 2023 | 36250634 | PubTator, text mining | PubMed |
| Divergent clinical outcomes in a phase 2B trial of the TLPLDC vaccine in preventing melanoma recurrence and the impact of dendritic cell collection methodology: a randomized clinical trial. | Cancer Immunol Immunother | 2023 | 36045304 | PubTator, text mining | PubMed |
| Photobiomodulation for Managing "Dry Socket": A Randomised Controlled Trial. | Int Dent J | 2023 | 35803777 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55/papers?page=12